Induction of sterile immunity against sporozoite and liver stages of malaria is a long-standing aim in vaccine development. Genetically engineered, attenuated sporozoites were systematically evaluated in animal models. Murphy et al. present the first, promising clinical trial of early arresting parasites, PfGAP3KO, confirming safety and demonstrating efficacy against homologous challenge.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.molmed.2022.11.005 | DOI Listing |
Publication Analysis
Top Keywords
genetically modified
4
modified malaria
4
malaria parasites
4
parasites vaccine
4
vaccine candidates
4
candidates induction
4
induction sterile
4
sterile immunity
4
immunity sporozoite
4
sporozoite liver
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!